SynthesisFrontiers in pharmacology2022

Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow.

Hongxin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.